Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure.
- Published in:
- Pharmacoepidemiology (2813-0618), 2022, v. 1, n. 3, p. 89, doi. 10.3390/pharma1030009
- By:
- Publication type:
- Article
Works matching IS 28130618 AND DT 2022 AND VI 1 AND IP 3
Results: 2
1
2
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States.
- Published in:
- Pharmacoepidemiology (2813-0618), 2022, v. 1, n. 3, p. 101, doi. 10.3390/pharma1030010
- By:
- Publication type:
- Article